Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in men with idiopathic oligozoospermia (Q44615913)

4 December 2017

title

Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in men with idiopathic oligozoospermia (English)

1 reference

4 December 2017

1 reference

1 reference

1 reference

Athina Pappa

1 reference

4 December 2017

Evangelia Billa

1 reference

4 December 2017

Stamatina Nicopoulou

1 reference

4 December 2017

Eftychia Koukkou

1 reference

4 December 2017

John Michopoulos

1 reference

4 December 2017

Dimitrios A. Adamopoulos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556812

20 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

http://www.fertstert.org/article/S0015028203011233/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556812

https://api.elsevier.com/content/article/PII:S0015028203011233?httpAccept=text/xml

20 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0015-0282(03)01123-3

https://api.elsevier.com/content/article/PII:S0015028203011233?httpAccept=text/plain

20 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0015-0282(03)01123-3

20 March 2024

published in

Fertility and Sterility

1 reference

4 December 2017

1 reference

4 December 2017

1 reference

4 December 2017

page(s)

914-920

1 reference

Hormonal effects of tamoxifen in oligospermic men

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

Tamoxifen suppresses gonadotropin-induced 17 alpha-hydroxyprogesterone accumulation in normal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

Tamoxifen treatment in male infertility. I. Effect on spermatozoa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

Increased sperm count in 25 cases of idiopathic normogonadotropic oligospermia following treatment with tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

The effective cumulative pregnancy rate of different modes of treatment of male infertility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

The combination of testosterone undecanoate with tamoxifen citrate enhances the effects of each agent given independently on seminal parameters in men with idiopathic oligozoospermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

Analysis of medical treatment of male infertility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

Hormone levels in the reproductive system of normospermic men and patients with oligospermia and varicocele

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

Leydig cell function in infertile men with idiopathic oligospermic infertility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

Endocrine effects of testosterone undecanoate as a supplementary treatment to menopausal gonadotropins or tamoxifen citrate in idiopathic oligozoospermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

Clinical andrology: from evidence-base to ethics. The 'E' quintet in clinical andrology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

The pharmacology and clinical uses of tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

Sperm morphologic features as a prognostic factor in in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

Spontaneous improvement in semen quality: regression towards the mean

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901123-3

Hormonal Effects of an Antiestrogen, Tamoxifen, in Normal and Oligospermic Men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(03)01123-3

20 March 2024

Identifiers

DOI

1 reference

4 December 2017

1 reference